WHO recommends antiviral drug for patients with non-severe COVID-19 at highest risk of hospital admission
COVID-19 restrictions linked to nearly 750,000 fewer dengue cases in 2020
2 March 2022WHO recommends Merck COVID pill for non-severe, at-risk patients
3 March 2022WHO recommends antiviral drug for patients with non-severe COVID-19 at highest risk of hospital admission
The antiviral drug molnupiravir is conditionally recommended for patients with non-severe COVID-19 who are at highest risk of hospitalization, says a WHO Guideline Development Group of international experts in The BMJ today.
